|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q89065753
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010858.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q89065753
|
|
024
|
|
|
‡a
0000-0003-0583-0882
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q89065753
|
|
100
|
0 |
|
‡a
Emily Nash Smyth
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Emily Nash Smyth
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis
|
|
670
|
|
|
‡a
Author's Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.
|
|
670
|
|
|
‡a
Author's TMOD-11. HUMAN STEM CELL BASED MODEL OF MEDULLOBLASTOMA
|
|
909
|
|
|
‡a
(orcid) 0000000305830882
‡9
1
|
|
919
|
|
|
‡a
engineeringgeneticpredispositioninhumanneuroepithelialstemcellsrecapitulatesmedulloblastomatumorigenesis
‡A
Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis
‡9
1
|
|
919
|
|
|
‡a
tmod11humanstemcellbasedmodelofmedulloblastoma
‡A
TMOD-11. HUMAN STEM CELL BASED MODEL OF MEDULLOBLASTOMA
‡9
1
|
|
919
|
|
|
‡a
patientreportedpainandotherqualityoflifedomainsasprognosticfactorsforsurvivalinaphase3clinicaltrialofpatientswithadvancedbreastcancer
‡A
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000371318262
|
|
996
|
|
|
‡2
CAOONL|ncf10638089
|
|
996
|
|
|
‡2
PLWABN|9810609085005606
|
|
996
|
|
|
‡2
LC|no2012065610
|
|
996
|
|
|
‡2
J9U|987012292209205171
|
|
996
|
|
|
‡2
LC|no2023022435
|
|
996
|
|
|
‡2
LC|nr 92039786
|
|
996
|
|
|
‡2
BIBSYS|19181
|
|
996
|
|
|
‡2
ISNI|0000000459544897
|
|
996
|
|
|
‡2
BNF|16427590
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
